3-[5-(1H-imidazol-1-yl)-7-methyl-1H-benzimidazol-2-yl]-4-[(pyridin-2-ylmethyl)amino]pyridin-2(1H)-one

This compound is a synthetic small molecule with the molecular formula C22H19N7O and a molecular weight of approximately 397.4 g/mol. It is listed in chemical and pharmaceutical databases such as PubChem (CID:135530418), ChEMBL (CHEMBL397666), DrugBank (DB07474), and ZINC15 as a pharmaceutical agent[1][7]. The structure features an imidazole ring fused to a methylated benzimidazole core with additional substitution by an aminopyridinone moiety linked to a pyridine group. There is no evidence from available sources that this compound has been approved for clinical use or assigned any brand name; it appears primarily in research contexts or as part of screening libraries for drug discovery. Its mechanism of action, biological targets, therapeutic indications, developers or manufacturers are not specified in public records[1][7]. It may be under investigation as a potential kinase inhibitor or other enzyme modulator based on its structural class but no specific pharmacological data are available.

Other names

3-[5-(1h-imidazol-1-Yl)-7-methyl-1h-benzimidazol-2-Yl]-4-[(pyridin-2-Ylmethyl)amino]pyridin-2(1h)-one3-(5-(1H-imidazol-1-Yl)-7-methyl-1H-benzimidazol -2-Yl)-4-( (Pyridin -2 -Ylmethyl )amino ) pyridin -2 ( 1 H ) -one3-(6-(1H-imidazol - 1 - yl ) -4-methyl - 1 H – 13 – benzo diazol – 2 – yl )–4–(( pyridin–2–ylmethyl) amino)–12-dihydropyridin–20-one